Io Biotech Inc (IOBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,143 | -19,457 | -86,083 | -59,901 | -38,222 |
| Depreciation Amortization | 127 | 62 | 215 | 156 | 102 |
| Accounts payable and accrued liabilities | 1,139 | -38 | -126 | 2,641 | 460 |
| Other Working Capital | -5,958 | -7,715 | 5,862 | 3,829 | 1,665 |
| Other Operating Activity | 2,921 | 2,216 | 8,395 | 4,333 | 3,043 |
| Operating Cash Flow | $-41,914 | $-24,932 | $-71,737 | $-48,942 | $-32,952 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -11 | -323 | -211 | -187 |
| Investing Cash Flow | $-23 | $-11 | $-323 | $-211 | $-187 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 75,058 | 75,058 | N/A |
| Other Financing Activity | 0 | 0 | -3,198 | -3,188 | 0 |
| Financing Cash Flow | $N/A | $N/A | $71,860 | $71,870 | $N/A |
| Exchange Rate Effect | -509 | -268 | 803 | 194 | 644 |
| Beginning Cash Position | 143,461 | 143,461 | 142,858 | 142,858 | 142,858 |
| End Cash Position | 101,015 | 118,250 | 143,461 | 165,769 | 110,363 |
| Net Cash Flow | $-42,446 | $-25,211 | $603 | $22,911 | $-32,495 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,914 | -24,932 | -71,737 | -48,942 | -32,952 |
| Capital Expenditure | -23 | -11 | -323 | -211 | -187 |
| Free Cash Flow | -41,937 | -24,943 | -72,060 | -49,153 | -33,139 |